157 related articles for article (PubMed ID: 7510243)
1. Leishmania major-specific CD8+ T cells are inducers and targets of nitric oxide produced by parasitized macrophages.
Stefani MM; Müller I; Louis JA
Eur J Immunol; 1994 Mar; 24(3):746-52. PubMed ID: 7510243
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
Moll H; Flohé S; Röllinghoff M
Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
[TBL] [Abstract][Full Text] [Related]
3. Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages.
Liew FY; Li Y; Moss D; Parkinson C; Rogers MV; Moncada S
Eur J Immunol; 1991 Dec; 21(12):3009-14. PubMed ID: 1721024
[TBL] [Abstract][Full Text] [Related]
4. Leishmania major infection in mice primes for specific major histocompatibility complex class I-restricted CD8+ cytotoxic T cell responses.
da Conceição-Silva F; Perlaza BL; Louis JA; Romero P
Eur J Immunol; 1994 Nov; 24(11):2813-7. PubMed ID: 7957573
[TBL] [Abstract][Full Text] [Related]
5. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
[TBL] [Abstract][Full Text] [Related]
6. Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.
Pinelli E; Gonzalo RM; Boog CJ; Rutten VP; Gebhard D; del Real G; Ruitenberg EJ
Eur J Immunol; 1995 Jun; 25(6):1594-600. PubMed ID: 7614987
[TBL] [Abstract][Full Text] [Related]
7. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages.
Liew FY; Li Y; Severn A; Millott S; Schmidt J; Salter M; Moncada S
Eur J Immunol; 1991 Oct; 21(10):2489-94. PubMed ID: 1717284
[TBL] [Abstract][Full Text] [Related]
8. Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis.
Wang ZE; Reiner SL; Hatam F; Heinzel FP; Bouvier J; Turck CW; Locksley RM
J Immunol; 1993 Aug; 151(4):2077-86. PubMed ID: 8102158
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
[TBL] [Abstract][Full Text] [Related]
10. Lack of inducible nitric oxide synthase activity in T cell clones and T lymphocytes from naive and Leishmania major-infected mice.
Thüring H; Stenger S; Gmehling D; Röllinghoff M; Bogdan C
Eur J Immunol; 1995 Dec; 25(12):3229-34. PubMed ID: 8566005
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of macrophage stimulation through CD8: macrophage CD8alpha and CD8beta induce nitric oxide production and associated killing of the parasite Leishmania major.
Hirji N; Lin TJ; Bissonnette E; Belosevic M; Befus AD
J Immunol; 1998 Jun; 160(12):6004-11. PubMed ID: 9637515
[TBL] [Abstract][Full Text] [Related]
12. Role of inflammatory infiltrate in activation and effector function of cloned islet reactive nonobese diabetic CD8+ T cells: involvement of a nitric oxide-dependent pathway.
Gurlo T; Kawamura K; von Grafenstein H
J Immunol; 1999 Dec; 163(11):5770-80. PubMed ID: 10570259
[TBL] [Abstract][Full Text] [Related]
13. Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8+ T cells.
Kima PE; Ruddle NH; McMahon-Pratt D
J Immunol; 1997 Aug; 159(4):1828-34. PubMed ID: 9257846
[TBL] [Abstract][Full Text] [Related]
14. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
15. Altered immune responses in mice lacking inducible nitric oxide synthase.
Wei XQ; Charles IG; Smith A; Ure J; Feng GJ; Huang FP; Xu D; Muller W; Moncada S; Liew FY
Nature; 1995 Jun; 375(6530):408-11. PubMed ID: 7539113
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major.
Ehrchen J; Helming L; Varga G; Pasche B; Loser K; Gunzer M; Sunderkötter C; Sorg C; Roth J; Lengeling A
FASEB J; 2007 Oct; 21(12):3208-18. PubMed ID: 17551101
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha mediates the induction of nitric oxide synthase in macrophages but not in neutrophils in experimental cutaneous leishmaniasis.
Fonseca SG; Romão PR; Figueiredo F; Morais RH; Lima HC; Ferreira SH; Cunha FQ
Eur J Immunol; 2003 Aug; 33(8):2297-306. PubMed ID: 12884305
[TBL] [Abstract][Full Text] [Related]
18. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major.
Assreuy J; Cunha FQ; Epperlein M; Noronha-Dutra A; O'Donnell CA; Liew FY; Moncada S
Eur J Immunol; 1994 Mar; 24(3):672-6. PubMed ID: 8125136
[TBL] [Abstract][Full Text] [Related]
19. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
[TBL] [Abstract][Full Text] [Related]
20. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation.
Gazzinelli RT; Eltoum I; Wynn TA; Sher A
J Immunol; 1993 Oct; 151(7):3672-81. PubMed ID: 7690809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
